Role of angiotensin II-induced cAMP in mesangial TNF-alpha production

Cytokine. 2002 Jul 7;19(1):47-51. doi: 10.1006/cyto.2002.1040.

Abstract

Previous findings indicated that cAMP had an inhibitory effect of on tumour necrosis factor (TNF)-alpha production. Angiotensin II (Ang II) may activate the cAMP-protein kinase A (PKA) pathway in renal mesangial cells through synthesis of prostaglandins (PGs) and the possibility arises that inhibition of Ang II-induced cAMP formation might result in the overproduction of TNF-alpha in the cell and this hypothesis was tested in the present study. Rat mesangial cells were exposed to Ang II in the presence or absence of cyclooxygenase inhibitor (indomethacin) or cAMP-PKA inhibitor (H-89). Exposure of mesangial cell to Ang II (10(-6)M-10(-8)M) significantly increased intracellular cAMP level through type 1 Ang II receptor but had no effect on TNF-alpha protein release, transcriptional activity, or mRNA. However, following the addition of indomethacin or H-89, Ang II significantly increased TNF-alpha release, transcriptional activity, and mRNA level. These data suggested that in mesangial cells after blockade of cAMP-PKA by PG inhibition, Ang II was capable of stimulating TNF-alpha transcription which subsequently increased TNF-alpha mRNA accumulation and protein release.

MeSH terms

  • Angiotensin II / physiology*
  • Animals
  • Blotting, Northern
  • Cyclic AMP / metabolism*
  • Genes, Reporter
  • Glomerular Mesangium / pathology
  • Indomethacin / pharmacology
  • Isoquinolines / pharmacology
  • Prostaglandins / metabolism
  • RNA, Messenger / metabolism
  • Rats
  • Sulfonamides*
  • Time Factors
  • Transcription, Genetic / drug effects
  • Tumor Necrosis Factor-alpha / biosynthesis*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Isoquinolines
  • Prostaglandins
  • RNA, Messenger
  • Sulfonamides
  • Tumor Necrosis Factor-alpha
  • Angiotensin II
  • Cyclic AMP
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
  • Indomethacin